BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE84.75-2.55 (-2.92 %)
PREV CLOSE ( ) 87.30
OPEN PRICE ( ) 87.30
BID PRICE (QTY) 84.76 (50)
OFFER PRICE (QTY) 87.30 (41)
VOLUME 24
TODAY'S LOW / HIGH ( )84.75 87.30
52 WK LOW / HIGH ( )76.5 125.55
NSE86.80-0.7 (-0.8 %)
PREV CLOSE( ) 87.50
OPEN PRICE ( ) 85.15
BID PRICE (QTY) 85.10 (1700)
OFFER PRICE (QTY) 86.80 (10)
VOLUME 1478
TODAY'S LOW / HIGH( ) 85.10 86.95
52 WK LOW / HIGH ( )75.9 124.45
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.